| Issue |
J Oral Med Oral Surg
Volume 24, Number 2, June 2018
|
|
|---|---|---|
| Page(s) | 72 - 75 | |
| Section | Cas clinique et revue de la littérature / Up-to date review and case report | |
| DOI | https://doi.org/10.1051/mbcb/2017033 | |
| Published online | 29 June 2018 | |
Up-to Date Review And Case Report
Papulopustular lesions of the face caused by panitumumab: case report and literature review
1
Oral Surgery Department, CHU de Rennes,
2 rue Henri le Guilloux,
35000
Rennes, France
2
Stomatology and Maxillofacial Surgery Department, Centre Hospitalier Départemental de Vendée,
Boulevard Stéphane Moreau,
85000
La Roche-sur-Yon, France
* Correspondence: johnr1988@hotmail.fr.
Received:
31
October
2017
Accepted:
19
December
2017
Introduction: Panitumumab (VECTIBIX®) is a monoclonal antibody used alone or in combination with a chemotherapy for management of metastatic colorectal cancer. Observation: A patient treated with this protocol manifested skin lesions; the etiological diagnosis was difficult. The lesions, namely a papulopustular rash at the lower third of the face, and the medical history allowed to diagnose an acute skin toxicity case due to this monoclonal antibody. Commentary: Many side effects are related to the panitumumab, among which dermatologic adverse events having already been the subject of some publications. Nevertheless, several studies conclude that the therapeutic benefit of this epidermal growth factor receptor inhibitor makes acceptable these complications. Conclusion: Stop treatment and corticosteroids allowed a whole and quick disappearance of skin lesions. Alongside dermatologists and infectious diseases specialists, the opinion of an oral surgeon was useful to provide an answer to these symptoms.
Key words: panitumumab / drug toxicity / acneiform eruption
© The authors, 2018
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.